Press Releases

H3 Pharma Inc. announces important step in bringing SANVAR® (vapreotide) to U.S. market

H3 Pharma Inc. Licenses in Sanvar ® (vapreotide) from Debiopharm S.A.

DEBIOPHARM S.A. licenses-in a compound from Genodyssee S.A.

Debiopharm S.A. provides funding to Tulane University

Debiopharm S.A. announces a patent application on a hydrosoluble prodrug of cyclosporin A

Debiopharm S.A. licenses-in new technology to turn injectable macromolecular drugs into oral formulations

Debiopharm and Biolex sign collaboration

Debiopharm extends its collaboration with Sanofi-Synthélabo on Eloxatin®

Media Alert: successful registration after shortest ever review by the FDA of Eloxatin